Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

IRWD POWR Grades

• IRWD scores best on the Value dimension, with a Value rank ahead of 97.58% of US stocks.
• IRWD's strongest trending metric is Growth; it's been moving down over the last 157 days.
• IRWD's current lowest rank is in the Momentum metric (where it is better than 9.43% of US stocks).

IRWD Stock Summary

• IRWD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 5.79 -- higher than 25.13% of US-listed equities with positive expected earnings growth.
• With a price/earnings ratio of 3.62, Ironwood Pharmaceuticals Inc P/E ratio is greater than that of about merely 3.17% of stocks in our set with positive earnings.
• The volatility of Ironwood Pharmaceuticals Inc's share price is greater than that of 27.87% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to IRWD, based on their financial statements, market capitalization, and price volatility, are PTE, NBIX, GTYH, AFIB, and KTOS.
• Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

• In comparison to the median Healthcare stock, IRWD's price/sales ratio is 36.84% higher, now standing at 5.2.
• Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.
• Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.

Below are key valuation metrics over time for IRWD.

IRWD Growth Metrics

The 3 year cash and equivalents growth rate now stands at -57.26%.
• Its 4 year net cashflow from operations growth rate is now at 236.25%.
• Its 5 year cash and equivalents growth rate is now at -17.42%.

Over the past 33 months, IRWD's revenue has gone up $66,664,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	413.303	248.84	530.278
2021-06-30	413.024	227.407	508.856
2021-03-31	398.425	198.927	142.757
2020-12-31	389.523	168.836	106.176
2020-09-30	399.144	144.903	110.83
2020-06-30	426.843	126.038	97.055

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
• IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
• LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.